| 1.2 |
3.7 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 1.1 |
3.2 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.8 |
2.3 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.7 |
2.2 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.6 |
3.2 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.6 |
3.6 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.6 |
2.3 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.5 |
4.0 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.5 |
2.3 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.3 |
1.3 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.2 |
2.0 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.2 |
0.5 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.2 |
1.7 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.2 |
1.1 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
| 0.2 |
0.5 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) protein K29-linked ubiquitination(GO:0035519) |
| 0.2 |
0.6 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
0.6 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.1 |
0.4 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.3 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.1 |
1.9 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.3 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
1.8 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.5 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.3 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.1 |
0.9 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.5 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
1.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
0.4 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.1 |
0.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.2 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.1 |
0.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.5 |
GO:0031642 |
negative regulation of myelination(GO:0031642) negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 |
1.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.3 |
GO:0071267 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 0.0 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.8 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.0 |
0.2 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.0 |
1.7 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.0 |
0.3 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.4 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.0 |
0.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
2.0 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.3 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.0 |
0.8 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.5 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.0 |
0.4 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.1 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.0 |
0.4 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
1.0 |
GO:0051220 |
cytoplasmic sequestering of protein(GO:0051220) |
| 0.0 |
0.1 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 |
0.2 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.0 |
0.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
1.5 |
GO:0098656 |
anion transmembrane transport(GO:0098656) |